The Efficacy of Combining EGFR Monoclonal Antibody With Chemotherapy for Patients With Advanced Nonsmall Cell Lung Cancer: A Meta-Analysis From 9 Randomized Controlled Trials

Although epidermal growth factor receptor (EGFR) monoclonal antibodies (mAbs) have been proved synergistic effect when combined with cytotoxic agents for advanced nonsmall cell lung cancer (NSCLC), the results of relevant clinical trials remain controversial. The purpose of this meta-analysis was to...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Medicine (Baltimore)
Egile Nagusiak: Sheng, Jin, Yang, Yun-Peng, Zhao, Yuan-Yuan, Qin, Tao, Hu, Zhi-Huang, Zhou, Ting, Zhang, Ya-Xiong, Hong, Shao-Dong, Ma, Yu-Xiang, Zhao, Hong-Yun, Huang, Yan, Zhang, Li
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wolters Kluwer Health 2015
Gaiak:
5700
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4602912/
https://ncbi.nlm.nih.gov/pubmed/26313787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000001400
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak